300519.SZ · 新光药业
China A-shares · RS rating 88 · As of 2026-10-14
| Price | 14.41 CNY |
|---|---|
| 1-day change | -2.2% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 79 / 88 / 60 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 31 / 27 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -38.8% |
| Distance from 52-week high | +17.9% |
| Market cap (USD) | $362.7M |